CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 467651-467810 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T34923","span":{"begin":0,"end":12},"obj":"Sentence"},{"id":"T35551","span":{"begin":13,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"CONCLUSIONS: Oral, once-daily roflumilast was associated with dose-dependent, clinically relevant improvements of lung function in patients with stable asthma."}

{"project":"Epistemic_Statements","denotations":[{"id":"T833","span":{"begin":0,"end":159},"obj":"Epistemic_statement"}],"text":"CONCLUSIONS: Oral, once-daily roflumilast was associated with dose-dependent, clinically relevant improvements of lung function in patients with stable asthma."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T172","span":{"begin":0,"end":12},"obj":"Sentence"},{"id":"T173","span":{"begin":13,"end":159},"obj":"Sentence"}],"text":"CONCLUSIONS: Oral, once-daily roflumilast was associated with dose-dependent, clinically relevant improvements of lung function in patients with stable asthma."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4620","span":{"begin":42,"end":45},"obj":"Disease"},{"id":"T4621","span":{"begin":152,"end":158},"obj":"Disease"}],"attributes":[{"id":"A4620","pred":"mondo_id","subj":"T4620","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A4621","pred":"mondo_id","subj":"T4621","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"CONCLUSIONS: Oral, once-daily roflumilast was associated with dose-dependent, clinically relevant improvements of lung function in patients with stable asthma."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T2547","span":{"begin":152,"end":158},"obj":"Phenotype"}],"attributes":[{"id":"A2547","pred":"hp_id","subj":"T2547","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"CONCLUSIONS: Oral, once-daily roflumilast was associated with dose-dependent, clinically relevant improvements of lung function in patients with stable asthma."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1046","span":{"begin":114,"end":118},"obj":"Body_part"}],"attributes":[{"id":"A1046","pred":"uberon_id","subj":"T1046","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"CONCLUSIONS: Oral, once-daily roflumilast was associated with dose-dependent, clinically relevant improvements of lung function in patients with stable asthma."}